Ascentage Pharma Group Inter Ownership
HK$31.70
7.24%
Hong Kong, Sep 21, 04:08 pm HKT.
Closed.
ISIN
KYG0519B1023
Symbol
6855
Industry
Ascentage Pharma Group Inter Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Takeda Pharmaceutical Co Ltd
|
24.307m | 6.51% | — | Dec 31 2024 |
| 2 |
Yang (Dajun)
|
23.152m | 6.20% | +23.087m | Dec 31 2024 |
| 3 |
SDIC Innovation Investment Management Co., Ltd.
|
15.696m | 4.20% | +15.696m | Sep 25 2024 |
| 4 |
Zhai (Yifan)
|
14.255m | 3.82% | +14.140m | Dec 31 2024 |
| 5 |
Guo (Edward Ming)
|
13.234m | 3.54% | +13.234m | Dec 31 2024 |
|
1
Takeda Pharmaceutical Co Ltd
|
6.51%
24.307m
|
|
2
Yang (Dajun)
|
6.20%
23.152m
|
|
3
SDIC Innovation Investment Management Co., Ltd.
|
4.20%
15.696m
|
|
4
Zhai (Yifan)
|
3.82%
14.255m
|
|
5
Guo (Edward Ming)
|
3.54%
13.234m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 24.27% of Ascentage Pharma Group Inter, with Takeda Pharmaceutical Co Ltd the biggest at 6.51%, followed by Yang (Dajun) (6.20%) and SDIC Innovation Investment Management Co., Ltd. (4.20%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
